Clinical and immunologic evaluation of prostatak for prostate cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA124032
- Recipient
-
Candel Therapeutics, Inc. UEI MPKRJM6FJFL8
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $7,303,403
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Auburndale, MA 02466, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $51,074 | |
| Amendment | $51,074 | |
| Amendment | $1,806,651 | |
| Amendment | $1,917,582 | |
| Amendment | $1,902,504 | |
| Amendment | $1,473,388 | |
| Original award | $101,130 |
Quick answers
Who received award R44CA124032?
R44CA124032 was awarded to Candel Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on August 10, 2007.
How much is award R44CA124032 worth?
$7,303,403 has been obligated on R44CA124032.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award